Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice

The emergence of three distinct highly pathogenic human coronaviruses – SARS-CoV in 2003, MERS-CoV in 2012, and SARS-CoV-2 in 2019 – underlines the need to develop broadly active vaccines against the Merbecovirus and Sarbecovirus betacoronavirus subgenera. While SARS-CoV-2 vaccines are highly protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, David R., Schafer, Alexandra, Gavitt, Tyler D., Mallory, Michael L., Lee, Esther, Catanzaro, Nicholas J., Chen, Haiyan, Gully, Kendra, Scobey, Trevor, Korategere, Pooja, Brown, Alecia, Smith, Lena, Parks, Rob, Barr, Maggie, Newman, Amanda, Bowman, Cindy, Powers, John M., Mansouri, Katayoun, Edwards, Robert J., Baric, Ralph S., Haynes, Barton F., Saunders, Kevin O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245799/
https://www.ncbi.nlm.nih.gov/pubmed/37293083
http://dx.doi.org/10.1101/2023.05.22.540829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245799/
https://www.ncbi.nlm.nih.gov/pubmed/37293083
http://dx.doi.org/10.1101/2023.05.22.540829

Ejemplares similares